Phase II study of CHOP-GR therapy in diffuse large B-cell lymphoma

• TAKEMURA Sachiya

  Department of Internal Medicine, Yokohama Ekisaikai Hospital

• TOMITA Naoto

  Department of Internal Medicine and Clinical Immunology, Yokohama City University Graduate School of Medicine

• KOHARAZAWA Hideyuki

  Department of Hematology, Yokohama City University Medical Center

• FUJIMAKI Katsumichi

  Department of Hematology and Immunology, Fujisawa City Hospital

• HARANO Hiroshi

  Department of Hematology, Yokosuka City Hospital

• HYO Rie

  Department of Hematology, Yokohama City University Medical Center

• YAMAZAKI Etsuko

  Department of Internal Medicine and Clinical Immunology, Yokohama City University Graduate School of Medicine

• HASHIMOTO Chizuko

  Department of Medical Oncology, Kanagawa Cancer Center

• MIYAZAKI Takuya

  Department of Internal Medicine and Clinical Immunology, Yokohama City University Graduate School of Medicine

• ISHIGATSUBO Yoshiaki

  Department of Internal Medicine and Clinical Immunology, Yokohama City University Graduate School of Medicine

収録刊行物

• International journal of hematology

  International journal of hematology 96 (2), 241-246, 2012-08-01

キーワード

• Diffuse large B cell lymphoma
• Rituximab
• Granulocyte colony stimulating factor
• Antibody-dependent cellular cytotoxicity
• Clinical trial

詳細情報

• CRID: 1573668925943925632
• NII論文ID: 10031042997
• NII書誌ID: AA10797094
• ISSN: 09255710
• 本文言語コード: en
• データソース種別:
  • CiNii Articles